Clear evidence. Clear ownership.

Articles exist to help someone choose and prepare for a provider Treomark lists: injectables, laser and skin treatments, IV therapy, medical weight loss, body contouring, practitioner licenses and supervision, and what a treatment costs and how it is quoted. A topic is published only when it connects to one of those decisions and there is evidence people are asking the question.

Articles outside that territory are kept available for existing readers but excluded from search indexes, the article hub, feeds, and related lists. New articles are checked against Treomark's price, provider, and practitioner pages first, so an article never competes with the page that answers the question with data.

Each claim cites the narrowest primary source that supports it, in this order:

1. FDA labels, databases, and safety communications; FTC materials; Florida statutes, administrative rules, and licensing boards.
2. Federal health agencies and evidence summaries such as NIH, CDC, and CMS.
3. Professional clinical guidelines and safety statements.
4. Original trials, systematic reviews, and peer-reviewed studies.
5. Manufacturer instructions or regulatory filings, for device mechanics and exact product claims only.

Clinic blogs, affiliate pages, and marketing do not establish safety, outcomes, legal scope, or comparisons. Every source is listed at the end of the article with what it supports and the date it was read. Regulatory terms are used literally: FDA approval, clearance, and registration are different things, and so are a license, a board certification, and a training certificate.

Articles are drafted with AI assistance. Jesse Delia, Treomark's founder and accountable editor, chooses each topic, checks that every statement matches the source it cites, edits the draft, and approves publication. The byline names him on every article.

Articles never invent prices, averages, outcomes, rankings, or firsthand experience. Where Treomark has its own data, such as advertised prices or practitioner license checks, the article links to it instead of estimating.

Clinical review is not yet part of the article process, and no clinician is credited as a reviewer. Articles explain evidence, regulation, and how to compare providers; they do not diagnose, recommend a treatment, or give legal advice. When a licensed reviewer joins, each reviewed article will name the reviewer, their credential, and the review date, and only on the articles they actually reviewed.

Published is the date an article first appeared. Source checked changes only when the sources are re-read or the content changes substantively; link and layout changes do not move it. High-risk regulatory and drug-label articles are reviewed at least every six months and immediately after a new FDA label or safety communication, a Florida rule change, or a broken primary source.

Anyone can report an error through the article corrections route. The editor checks the report against the cited sources, fixes confirmed errors, updates the source-checked date, and replies with the outcome.

Articles do not promote individual providers, and no provider can pay for an article, a mention, or a link. Links to Treomark's price, provider, and practitioner pages lead to data that follows the same rules for every provider. How Treomark earns money is explained on the About page.